Astellas-Pfizer's combination therapy halves risk of death in bladder cancer patients

Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...
New York Post

J&J’s bladder cancer treatment approved by FDA — paving way for potential surgery-free option

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
CURE

FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer

The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for ...
Nasdaq

Launch of Beova(R) Tablets in Thailand for Overactive Bladder

TOKYO, Jul 23, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku ...